Stifel Financial Corp Ani Pharmaceuticals Inc Transaction History

Stifel Financial Corp

$93.7 Billion
Q4 2024

A detailed history of Stifel Financial Corp transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Stifel Financial Corp holds 8,424 shares of ANIP stock, worth $502,744. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,424

Previous 6,999 20.36%

Holding current value

$502,744

Previous $417,000 11.51%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$53.35 - $61.74 $76,023 - $87,979	1,425 Added 20.36%	8,424 $465,000
Q3 2024 Nov 14, 2024	BUY	$54.33 - $65.72 $380,255 - $459,974	6,999 New	6,999 $417,000
Q1 2020 May 14, 2020	SELL	$30.35 - $67.14 $98,485 - $217,869	-3,245 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$55.65 - $79.83 $25,042 - $35,923	450 Added 16.1%	3,245 $201,000
Q3 2019 Nov 13, 2019	SELL	$64.7 - $85.39 $8,152 - $10,759	-126 Reduced 4.31%	2,795 $203,000
Q2 2019 Aug 14, 2019	SELL	$67.77 - $82.2 $7,725 - $9,370	-114 Reduced 3.76%	2,921 $242,000
Q1 2019 May 14, 2019	BUY	$45.83 - $70.54 $139,094 - $214,088	3,035 New	3,035 $214,000
Q4 2018 Feb 13, 2019	SELL	$41.17 - $56.44 $158,380 - $217,124	-3,847 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$52.95 - $71.34 $900 - $1,212	17 Added 0.44%	3,847 $217,000
Q2 2018 Aug 14, 2018	BUY	$56.38 - $68.08 $9,246 - $11,165	164 Added 4.47%	3,830 $256,000
Q1 2018 May 11, 2018	BUY	$56.98 - $72.41 $208,888 - $265,455	3,666 New	3,666 $215,000
Q4 2017 Feb 14, 2018	SELL	$53.3 - $74.56 $357,269 - $499,775	-6,703 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$43.46 - $52.49 $291,312 - $351,840	6,703	6,703 $0

Others Institutions Holding ANIP

# of Institutions

212

Shares Held

18.3M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.04B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Ani Pharmaceuticals Inc Transaction History